CAR-T cell therapy


January 10, 2022

Safety & Speed: handling two major factors in CAR T-cell therapy

by Michael Eder

Reading time: 3 minutes

In order to allow for a smooth and functioning process, a reliable supply chain, tailored to the specific needs of autologous therapies, is a prerequisite. Single Use Support has developed an end-to-end process solution for cell and gene therapies.

December 22, 2021

Logistic solutions for CAR T-cell therapy – let’s scale!

by Michael Eder

Reading time: 4 minutes

Single Use Support develops scalable solutions and optimizes processes for protecting, fill & freeze, shockfreezing, packaging and handling of small volume cell and gene therapeutics. Learn more about logistics for CAR T-cell therapy!

Small batch manufacturing & fill-finish in cell and gene therapy

michael muehlegger by Michael Muehlegger

Reading time: 3 minutes

A great example is the treatment of insidious cancers with CAR T-cells, that relies on modifying the patient’s own T-cells to instill them with a targeted way to fight cancer cells. Learn more why forming strong collaborations will solve many issues!

December 20, 2021

Supply chain optimization in cell and gene therapies

Barbara Fischer, Single Use Support by Dr. Barbara M. Fischer

Reading time: 3 minutes

Single Use Support is solving problems related to supply chain management through the development of smart packaging and related smart technologies for CAR T-cell therapy. Read more!

Advanced therapy medicinal products – a new era of medicine

by Michael Eder

Reading time: 4 minutes

The aim to find solutions that address bottlenecks in pharmacology is a driving force at Single Use Support. The company is replacing established systems with single-use technologies that are compliant with any regulatory considerations (EMA and FDA) – read more!